374Water, Inc.

Nachricht vom 26.10.2021 | 19:55

374WATER EXPANDS INTO EUROPE Dr. Tali Harif Joins to lead EU Commercialization

DGAP-News: 374Water, Inc. / Key word(s): Expansion
26.10.2021 / 19:55
The issuer is solely responsible for the content of this announcement.

374WATER EXPANDS INTO EUROPE Dr. Tali Harif Joins to lead EU Commercialization

DURHAM, NC / ACCESSWIRE / October 26, 2021 / 374Water, Inc., a social impact, cleantech company, is pleased to announce that water industry veteran Dr. Tali Harif has joined the company as Business Development Director to accelerate the development and commercialization of 374Water's innovative AirSCWO systems in Europe.

With over 15 years of senior executive experience in the global water industry, Dr. Harif will be instrumental in establishing 374Water's European business, leading opportunities in the treatment of wastewater, biosolids, industrial waste, food waste, and landfill leachate.

"Tali is a water industry expert in technology, innovation management, and business development. She will be extremely valuable developing business and managing the opportunities we are fortunate to have in Europe," says CEO Kobe Nagar.

"I am extremely excited to join 374Water where, as an early advisor to the company, I've had the pleasure to see it transition from a university project supported by Duke University and the Gates Foundation to a company with a disruptive product able to provide solutions to multiple market verticals, now being manufactured at scale," says Dr. Harif.

AirSCWO is a revolutionary thermal-physical process that converts waste into water, energy, and minerals while eliminating "Forever Chemicals" (PFAS) and other emerging contaminants-a true paradigm shift in how the world treats waste.

Cautionary Language

This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning.

About 374Water

374Water, Inc. (SCWO), is a publicly traded company offering an innovative technology to process and eliminate "forever" chemicals from the natural and developed environments. Our mission is to preserve a clean and healthy environment that sustains life. We apply cutting-edge science and engineering prowess to recover resources from the wastes our society generates and along the way we help organizations achieve the Sustainable Development Goals (SDGs).

CONTACT: Mr. Richard Davis, ir@374Water.com, (786) 412-7015

Related Links: www.374water.com

SOURCE: 374Water, Inc.



26.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Neufassung der Dividendenpolitik der Allianz SE

02. Dezember 2021, 20:33

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021